Early-Onset Cancers: Investigating Etiology, Mechanisms, and Early Detection Strategies (RP1 Clinical Trials Optional)
- Not stated
- Not stated
- Oct 14, 2026
Official announcement on Grants.gov · opens the funder's page. Always confirm dates there.
Summary
This Notice of Funding Opportunity (NOFO) invites applications that investigate the etiology of sporadic non-hereditary early-onset cancers (EOCs: ages 18 to 49 years) and the underlying biological mechanisms that play a role in these cancers to inform prevention and control strategies…
Preparing an application?
On Plus, $39 a month
- The eligibility check against your profile: career stage, institution type, and the windows that close before the deadline does
More from National Institutes of Health
Population Assessment of Tobacco and Health (PATH) Study Biospecimen Access (X01)
GREGoRi Innovation Projects (U01 Clinical Trial Optional)
$500k
GREGoRi Data Coordination and Outreach Center (U01, Clinical Trials Not Allowed)
$1.3M
GREGoRi Technology Integration Center (U01, Clinical Trials Optional)
$2.3M